🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

D. Williams Parsons

Baylor College of Medicine

ORCID: 0000-0002-8775-3501

Also affiliated with Texas Children's Hospital, Children's Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
12.5Author DataRank

Indexed papers

6in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 6 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Consensus Coding Sequences of Human Breast and Colorectal Cancers

Science(2006)10.1126/science.1133427
Top 1%
11.9DataRank
Top 1%3178 citations

Siân Jones, Laura D. Wood, D. Williams Parsons, Jimmy Lin, Thomas D. Barber +26 more

Papers

Driven by 28 papers — median percentile 41. Top paper: “The Consensus Coding Sequences of Human Breast and Colorectal Cancers”.

The Consensus Coding Sequences of Human Breast and Colorectal Cancers

Science(2006)10.1126/science.1133427
Top 1%
11.9DataRank
Top 1%3178 citations

Siân Jones, Laura D. Wood, D. Williams Parsons, Jimmy Lin, Thomas D. Barber +26 more

Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors

Journal of Clinical Oncology(2024)10.1200/jco.23.02019
N/A
1.8DataRank · unranked
75 citations

Austin J. Stuckert, Candise Tat, Mark D. White, Lucia Ruggieri, Huimin Zhang +30 more

Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute–Children's Oncology Group Pediatric MATCH Trial

Journal of Clinical Oncology(2022)10.1200/jco.21.02838
N/A
0.722DataRank · unranked
122 citations

Katherine A. Janeway, David R. Patton, Cynthia L. Winter, Brent Coffey, P. Mickey Williams +16 more

Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad085
N/A
0.685DataRank · unranked
95 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +17 more

ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1066
N/A
0.681DataRank · unranked
93 citations

Yanhua Zhao, Srinidhi Varadharajan, Hsiao‐Chi Chen, Selin Jessa, Bryan Rivas +36 more

Reliable tumor detection by whole-genome methylation sequencing of cell-free DNA in cerebrospinal fluid of pediatric medulloblastoma

Science Advances(2020)10.1126/sciadv.abb5427
N/A
0.673DataRank · unranked
88 citations

Sibo Zhao, Minjung Lee, Yue Yin, Jin Li, Yubin Zhou +9 more

Ulixertinib in patients with tumors with MAPK pathway alterations: Results from NCI-COG Pediatric MATCH trial Arm J (APEC1621J).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.3009
N/A
0.518DataRank · unranked
16 citations

Amit J. Sabnis, Paul M. Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures

Cancer(2024)10.1002/cncr.35301
N/A
0.510DataRank · unranked
29 citations

Peter Dimitrion, Oussama Abla, Simon Bomken, Patrick Campbell, Matthew Collin +27 more

Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma

Translational Oncology(2022)10.1016/j.tranon.2022.101368
N/A
0.483DataRank · unranked
24 citations

Lin Qi, Yuchen Du, Frank Braun, Huiyuan Zhang, Lei Huang +19 more

Tazemetostat in patients with tumors with alterations in EZH2 or the SWI/SNF complex: Results from NCI-COG Pediatric MATCH trial Arm C (APEC1621C).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10009
N/A
0.464DataRank · unranked
21 citations

Joanna S. Yi, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas

Nature Communications(2022)10.1038/s41467-022-34514-z
N/A
0.449DataRank · unranked
19 citations

Jia Li, Huiyuan Zhang, Lin Qi, Yuchen Du, Mari Kogiso +29 more

Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G

The Oncologist(2024)10.1093/oncolo/oyae119
N/A
0.363DataRank · unranked
7 citations

AeRang Kim, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +17 more

Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2785
N/A
0.292DataRank · unranked
6 citations

Lisa Golmard, Jung Kim, Riyue Bao, Frank Y. Lin, Angshumoy Roy +32 more

Combined bioinformatic and splicing analysis of likely benign intronic and synonymous variants reveals evidence for pathogenicity

Genetics in Medicine Open(2024)10.1016/j.gimo.2024.101850
Top 56%
0.292DataRank
Top 56%4 citations

Stephanie A. Felker, Surya P. Rednam, Kelly Vallance, D. Williams Parsons, Angshumoy Roy +3 more

Update for NCI-COG Pediatric MATCH: Active trial cohorts for children, adolescents and young adults with refractory cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps10071
Top 59%
0.257DataRank
Top 59%3 citations

Katherine A. Janeway, Theodore W. Laetsch, Meredith S. Irwin, Elizabeth Alva, Christine A. Pratilas +14 more

Palbociclib in solid tumor patients with genomic alterations in the cyclin D-CDK4/6-INK4a-Rb pathway: Results from NCI-COG pediatric MATCH trial Arm I (APEC1621I).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10006
N/A
0.241DataRank · unranked
4 citations

Rajen Mody, Joel M. Reid, Jin Piao, Lauren Saguilig, Todd A. Alonzo +14 more

Factors impacting enrollment on NCI-COG Pediatric MATCH trial treatment protocols.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10007
N/A
0.208DataRank · unranked
3 citations

Katherine A. Janeway, David R. Patton, Jennifer Lee, Brent Coffey, P. Mickey Williams +16 more

Selumetinib in patients with tumors with MAPK pathway alterations: Results from Arm E of the NCI-COG pediatric MATCH trial.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10008
N/A
0.165DataRank · unranked
2 citations

Olive S. Eckstein, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Supplementary Data 1 from Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition

Figshare(2025)10.1158/1078-0432.29052943
Top 100%
0DataRank
Top 100%0 citations

Lisa Golmard, Jung Kim, Riyue Bao, Frank Y. Lin, Angshumoy Roy +32 more

Figure S3 from Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition

Figshare(2025)10.1158/1078-0432.29052952
N/A
0DataRank · unranked
0 citations

Lisa Golmard, Jung Kim, Riyue Bao, Frank Y. Lin, Angshumoy Roy +32 more

Figure S2 from Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition

Figshare(2025)10.1158/1078-0432.29052955
N/A
0DataRank · unranked
0 citations

Lisa Golmard, Jung Kim, Riyue Bao, Frank Y. Lin, Angshumoy Roy +32 more

Integrated DNA and RNA sequencing reveals targetable alterations in metastatic pediatric papillary thyroid carcinoma

Pediatric Blood & Cancer(2020)10.1002/pbc.28741
N/A
0DataRank · unranked
25 citations

Jacquelyn Reuther, Raghu Chandramohan, Ilavarasi Gandhi, Faith Hollingsworth, Hadi Sayeed +14 more

The Challenge of Informed Consent and Return of Results in Translational Genomics: Empirical Analysis and Recommendations

UNC Libraries(2020)10.17615/nkba-1021
N/A
0DataRank · unranked
0 citations

Steven Joffe, Paul S. Appelbaum, Susan M. Wolf, Gail E. Henderson, Richard R. Sharp +4 more

Erdafitinb in patients with FGFR-altered tumors: Results from the NCI-COG Pediatric MATCH trial arm B (APEC1621B).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10007
N/A
0DataRank · unranked
20 citations

Alexander J. Chou, P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, Brent Coffey +15 more

Frequency and spectrum of clinically significant molecular alterations detected by tumor gene panel testing for pediatric cancer patients in the Texas KidsCanSeq study.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.10018
N/A
0DataRank · unranked
0 citations

Jacquelyn Reuther, Samara L. Potter, Ross Mangum, Carrie Mohila, John Hicks +15 more

Combined Bioinformatic and Splicing Analysis of Likely Benign Intronic and Synonymous Variants Reveals Evidence for Pathogenicity

medRxiv(2023)10.1101/2023.10.30.23297632
Top 100%
0DataRank
Top 100%0 citations

Stephanie A. Felker, Surya P. Rednam, Kelly Vallance, D. Williams Parsons, Angshumoy Roy +3 more

Supplementary Table Legend 1 from Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition

Figshare(2025)10.1158/1078-0432.29052940
N/A
0DataRank · unranked
0 citations

Lisa Golmard, Jung Kim, Riyue Bao, Frank Y. Lin, Angshumoy Roy +32 more

Figure S1 from Germline Pathogenic DROSHA Variants Are Linked to Pineoblastoma and Wilms Tumor Predisposition

(2025)10.1158/1078-0432.29052958
N/A
0DataRank · unranked
0 citations

Lisa Golmard, Jung Kim, Riyue Bao, Frank Y. Lin, Angshumoy Roy +32 more